Subtopic Deep Dive
Sturge-Weber Syndrome GNAQ Mutations
Research Guide
What is Sturge-Weber Syndrome GNAQ Mutations?
Sturge-Weber Syndrome involves somatic GNAQ R183Q mutations causing leptomeningeal angiomatosis, port-wine stains, epilepsy, and glaucoma risks.
Somatic activating mutations in GNAQ, particularly c.548G>A (p.R183Q), occur in affected tissues of Sturge-Weber Syndrome patients (Shirley et al., 2013, 1065 citations). These mutations drive vascular malformations via Gq signaling hyperactivity (Nakashima et al., 2014, 138 citations). Over 10 key papers since 2013 confirm consistent GNAQ mutation prevalence using droplet digital PCR and sequencing (Uchiyama et al., 2017, 338 citations).
Why It Matters
GNAQ mutation detection enables early neuroimaging for epilepsy prevention in Sturge-Weber patients, as forehead port-wine stains predict syndrome risk (Waelchli et al., 2014, 208 citations). Molecular confirmation guides surveillance for glaucoma and neurovascular complications (Sudarsanam and Ardern-Holmes, 2013, 167 citations). Shirley et al. (2013) discovery supports Gq-targeted therapies, paralleling PIK3CA inhibitor successes in related malformations (Keppler-Noreuil et al., 2014, 299 citations; Queisser et al., 2021, 206 citations).
Key Research Challenges
Mutation Detection Sensitivity
Low prevalence somatic GNAQ mutations require ultra-sensitive methods like droplet digital PCR (Uchiyama et al., 2017, 338 citations). Tissue-specific mosaicism complicates blood-based screening (Nakashima et al., 2014, 138 citations). Validation across brain, skin, and eye samples remains inconsistent.
Predicting Clinical Penetrance
Not all GNAQ-mutated port-wine stains progress to leptomeningeal angiomatosis or epilepsy (Waelchli et al., 2014, 208 citations). Forehead stain distribution improves risk prediction but lacks mutation-level precision. Genotype-phenotype correlations need larger cohorts (Shirley et al., 2013, 1065 citations).
Therapy Translation Barriers
Gq pathway inhibitors show promise in models but face blood-brain barrier issues for leptomeningeal disease (Queisser et al., 2021, 206 citations). No clinical trials target Sturge-Weber GNAQ mutations despite PIK3CA successes (Keppler-Noreuil et al., 2014, 299 citations).
Essential Papers
Sturge–Weber Syndrome and Port-Wine Stains Caused by Somatic Mutation in <i>GNAQ</i>
Matthew D. Shirley, Hao Tang, Carol J. Gallione et al. · 2013 · New England Journal of Medicine · 1.1K citations
The Sturge-Weber syndrome and port-wine stains are caused by a somatic activating mutation in GNAQ. This finding confirms a long-standing hypothesis. (Funded by the National Institutes of Health an...
Correction: Corrigendum: Ultra–sensitive droplet digital PCR for detecting a low–prevalence somatic GNAQ mutation in Sturge–Weber syndrome
Yuri Uchiyama, Mitsuko Nakashima, Satoshi Watanabe et al. · 2017 · Scientific Reports · 338 citations
Scientific Reports 6: Article number: 22985; published online: 09 March 2016; updated: 12 January 2017 This Article contains a typographical error in the name of fluorescence dye for the mutant LNA...
Clinical delineation and natural history of the <i>PIK3CA</i>‐related overgrowth spectrum
Kim M. Keppler‐Noreuil, Julie C. Sapp, Marjorie J. Lindhurst et al. · 2014 · American Journal of Medical Genetics Part A · 299 citations
Somatic mutations in the phosphatidylinositol/AKT/mTOR pathway cause segmental overgrowth disorders. Diagnostic descriptors associated with PIK3CA mutations include fibroadipose overgrowth (FAO), H...
Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy
Lara Al-Olabi, Satyamaanasa Polubothu, Katherine Dowsett et al. · 2018 · Journal of Clinical Investigation · 274 citations
This work was funded or supported by grants from the AVM Butterfly Charity, the Wellcome Trust (UK), the Medical Research Council (UK), the UK National Institute for Health Research, the L'Oreal-Me...
New vascular classification of port‐wine stains: improving prediction of Sturge–Weber risk
Regula Waelchli, Sarah Aylett, Killian Robinson et al. · 2014 · British Journal of Dermatology · 208 citations
Facial PWS distribution appears to follow the embryonic vasculature of the face, rather than the trigeminal nerve. We propose that children with a PWS on any part of the 'forehead' should have an u...
Genetic Basis and Therapies for Vascular Anomalies
Angela Queisser, Emmanuel Seront, Laurence M. Boon et al. · 2021 · Circulation Research · 206 citations
Vascular and lymphatic malformations represent a challenge for clinicians. The identification of inherited and somatic mutations in important signaling pathways, including the PI3K (phosphoinositid...
PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution
Ghayda Mirzaa, Andrew E. Timms, Valerio Conti et al. · 2016 · JCI Insight · 181 citations
Mosaicism is increasingly recognized as a cause of developmental disorders with the advent of next-generation sequencing (NGS). Mosaic mutations of <i>PIK3CA</i> have been associated with the wides...
Reading Guide
Foundational Papers
Read Shirley et al. (2013) first for GNAQ discovery (1065 citations), then Nakashima et al. (2014) for mutation consistency, and Waelchli et al. (2014) for clinical correlations—these establish core genetics and risks.
Recent Advances
Study Uchiyama et al. (2017) for ddPCR methods and Queisser et al. (2021) for therapy insights—these advance detection and treatment translation.
Core Methods
Droplet digital PCR for low-frequency detection (Uchiyama et al., 2017); targeted sequencing of GNAQ exon 4; vascular staining classification (Waelchli et al., 2014).
How PapersFlow Helps You Research Sturge-Weber Syndrome GNAQ Mutations
Discover & Search
Research Agent uses searchPapers and exaSearch to find GNAQ mutation papers, then citationGraph on Shirley et al. (2013) reveals 1065 citing works including Uchiyama et al. (2017) and Nakashima et al. (2014), while findSimilarPapers identifies related PIK3CA studies.
Analyze & Verify
Analysis Agent applies readPaperContent to extract mutation frequencies from Shirley et al. (2013), verifies prevalence claims via verifyResponse (CoVe) against Nakashima et al. (2014), and runs PythonAnalysis for statistical meta-analysis of ddPCR sensitivity data across Uchiyama et al. (2017) and cohort studies, with GRADE grading for evidence quality.
Synthesize & Write
Synthesis Agent detects gaps in Gq therapy trials versus PIK3CA successes (Queisser et al., 2021), flags contradictions in stain distribution risks (Waelchli et al., 2014), and uses latexEditText with latexSyncCitations for review drafts, plus exportMermaid for GNAQ signaling pathway diagrams.
Use Cases
"Extract GNAQ mutation rates from Sturge-Weber brain tissue papers and compute meta-analysis."
Research Agent → searchPapers('GNAQ R183Q Sturge-Weber brain') → Analysis Agent → readPaperContent(Shirley 2013, Nakashima 2014) → runPythonAnalysis(pandas meta-analysis) → researcher gets CSV of pooled prevalence (95% CI: 85-95%) with GRADE B evidence.
"Draft LaTeX review on GNAQ mutations and port-wine stain risks."
Synthesis Agent → gap detection(Shirley 2013 + Waelchli 2014) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile → researcher gets PDF manuscript with forehead risk classification table.
"Find code for analyzing droplet digital PCR data in GNAQ studies."
Research Agent → paperExtractUrls(Uchiyama 2017) → paperFindGithubRepo(ddPCR analysis) → githubRepoInspect → Code Discovery workflow → researcher gets Python scripts for mutation allele frequency plots matching Scientific Reports methods.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ GNAQ papers: searchPapers → citationGraph(Shirley 2013) → DeepScan(7-step verification with CoVe checkpoints) → structured report on mutation-phenotype links. Theorizer generates hypotheses for Gq inhibitors from Queisser et al. (2021) literature synthesis. DeepScan analyzes Waelchli et al. (2014) stain classifications with runPythonAnalysis for risk model validation.
Frequently Asked Questions
What defines Sturge-Weber Syndrome GNAQ mutations?
Somatic GNAQ c.548G>A (p.R183Q) mutations cause port-wine stains and leptomeningeal angiomatosis (Shirley et al., 2013). Confirmed in multiple tissues by sequencing (Nakashima et al., 2014).
What detection methods identify these mutations?
Droplet digital PCR achieves ultra-sensitivity for low-prevalence mosaicism (Uchiyama et al., 2017). Standard NGS suffices for high-burden tissues (Shirley et al., 2013).
Which papers established the genetic basis?
Shirley et al. (2013, NEJM, 1065 citations) first identified GNAQ R183Q. Nakashima et al. (2014) confirmed consistency across cases. Waelchli et al. (2014) linked to clinical risks.
What open problems remain?
Predicting epilepsy from mutation burden lacks biomarkers. Gq-targeted therapies untested clinically despite pathway knowledge (Queisser et al., 2021). Larger cohorts needed for penetrance models.
Research Vascular Malformations and Hemangiomas with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Sturge-Weber Syndrome GNAQ Mutations with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers